Nebivolol is a beta-blocker mainly used to treat high blood pressure (hypertension) and, in some cases, heart failure. It is available as an oral tablet, commonly under the brand name Bystolic. It is grouped under the following drug class(es): Beta blockers. Its therapeutic use is listed as angina, antihypertensives and cardiovascular. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Nebivolol, Nebivololum, Narbivolol and Bystolic. Its PubChem CID is 71301.
Nebivolol
| CAS No | 99200-09-6 |
|---|---|
| Molecular Formula | C22H25F2NO4 |
| Molecular Weight | 405.4 g/mol |
| Synonyms | 1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-[[2-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-hydroxyethyl]amino]ethanol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Nebivolol is a beta-blocker mainly used to treat high blood pressure (hypertension) and, in some cases, heart failure. It is available as an oral tablet, commonly under the brand name Bystolic.
The listed CAS number is 99200-09-6.
The listed molecular formula is C22H25F2NO4.
The listed molecular weight is 405.4 g/mol.
1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-[[2-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-hydroxyethyl]amino]ethanol.
The source lists Nebivolol, Nebivololum, Narbivolol and Bystolic.